A Comparison of Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Treated On versus Off Study

Participation in clinical trials is recommended for patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) who are treated with intensive induction therapy, but enrollment is often challenging.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Mary-Elizabeth Percival, Sarah Buckley, Megan Othus, Anna Halpern, Emily Huebner, Pamela Becker, Carole Shaw, Mazyar Shadman, Roland Walter, Elihu Estey Source Type: research